SyntheticMR announced that they have reached an agreement with one of their partners. This signed agreement means a commitment that the product package SyMRI NEURO will be sold globally in a significant volume. The agreement has great strategic value for the company and the sales value amounts to at least SEK 15 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27.7 SEK | +1.09% | -.--% | +4.14% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.14% | 106M | |
+4.71% | 32.58B | |
+16.47% | 7.65B | |
+23.49% | 3.92B | |
-15.80% | 3.19B | |
-27.19% | 1.26B | |
-33.58% | 1.14B | |
-33.74% | 926M | |
+1.56% | 908M | |
-23.93% | 859M |
- Stock Market
- Equities
- SYNT Stock
- News SyntheticMR AB
- SyntheticMR Signs Sales Agreement Regarding SyMRI NEURO